12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Monday's intraday session, several healthcare stocks experienced significant movements. Invivyd (IVVD) saw a sharp increase of 157.7%, while Panbela Therapeutics (PBLA) and Biomerica (BMRA) also posted substantial gains. Conversely, Cara Therapeutics (CARA), Checkpoint Therapeutics (CKPT), and Minerva Surgical (UTRS) were among the notable losers, with their stock prices falling significantly.
December 18, 2023 | 5:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cara Therapeutics' stock plummeted 46.7% to $0.66, with a market cap of $35.7 million.
The sharp decline in Cara Therapeutics' stock price suggests negative market sentiment or disappointing company developments, which could lead to further short-term downside risk.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Checkpoint Therapeutics' stock fell 46.69% to $1.77, with a market cap of $41.6 million.
The significant drop in Checkpoint Therapeutics' stock price could reflect adverse events or market reactions, potentially leading to further short-term selling pressure.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Minerva Surgical's stock decreased by 36.53% to $1.79, with a market cap of $15.8 million.
Minerva Surgical's stock decline could be indicative of negative news or investor sentiment, which may result in continued bearish behavior in the short term.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Biomerica's shares jumped 65.64% to $1.64, with a market cap of $27.5 million.
Biomerica's significant price increase could be driven by positive news or investor sentiment, which may lead to continued short-term interest and potential price appreciation.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Invivyd's stock soared by 157.7% to $4.2, with a market cap of $462.4 million.
The substantial increase in Invivyd's stock price suggests a very positive market reaction, likely due to favorable news or developments specific to the company. This could lead to increased investor interest and further short-term gains.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Panbela Therapeutics' stock rose 123.14% to $1.02, with a market cap of $5.2 million.
Panbela Therapeutics' significant stock price increase indicates strong investor optimism. The magnitude of the rise could attract more attention and potentially lead to further short-term upward momentum.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100